What drug is used for ventricular tachycardia?
I'll answer
Earn 20 gold coins for an accepted answer.20
Earn 20 gold coins for an accepted answer.
40more
40more
Benjamin Lee
Works at Apple, Lives in Cupertino, CA
As a medical professional with expertise in cardiology, I can provide you with information on the treatment of ventricular tachycardia (VT). Ventricular tachycardia is a serious heart rhythm disorder that can lead to a life-threatening condition called ventricular fibrillation. The treatment for VT depends on the stability of the patient and the underlying cause of the arrhythmia.
In an acute setting, the first-line treatment for ventricular tachycardia often involves the use of antiarrhythmic drugs. One of the most commonly used antiarrhythmic medications for this condition is lidocaine. Lidocaine is a sodium channel blocker that helps to stabilize the electrical activity of the heart.
Other antiarrhythmic drugs that may be used include:
- Procainamide: Another sodium channel blocker, often used when lidocaine is ineffective or contraindicated.
- Amiodarone: A multi-channel blocker with a complex mechanism of action, used for more resistant cases of VT.
- Sotalol: A beta-blocker with class III antiarrhythmic properties, which can be used for both atrial and ventricular arrhythmias.
In addition to pharmacological interventions, other treatments may include:
- Cardioversion: An electrical shock to the heart to restore normal rhythm, used when medications are not effective or not tolerated.
- **Implantable Cardioverter Defibrillator (ICD)**: A device that can detect and treat VT or ventricular fibrillation with a shock.
It is important to note that the choice of medication and treatment strategy should be tailored to the individual patient's condition and should be determined by a healthcare professional.
Works at Oracle, Lives in Redwood City, CA
In the United Sates, the intravenous (IV) antiarrhythmic drugs available for suppression of acute monomorphic VT are limited to procainamide, lidocaine, and amiodarone, along with the beta-adrenergic blocking agents metoprolol, esmolol, and propranolol.
2017-12-5
评论(0)
Helpful(2)
Helpful
Helpful(2)
Lucas Parker
QuesHub.com delivers expert answers and knowledge to you.
In the United Sates, the intravenous (IV) antiarrhythmic drugs available for suppression of acute monomorphic VT are limited to procainamide, lidocaine, and amiodarone, along with the beta-adrenergic blocking agents metoprolol, esmolol, and propranolol.